Proud Kakinada is at the heart of India’s return to making Penicillin, says Andhra HRD Minister Nara Lokesh
Lyfius Pharma Private Limited's facility in Kakinada SEZ is helping India cut its dependence on imported raw materials for essential antibiotics, the Minister says in a social media post
Proud Kakinada is playing a central role in India's resurgence in penicillin production, according to Andhra Pradesh HRD Minister Nara Lokesh. The Minister highlighted the significance of Lyfius Pharma Private Limited's Penicillin-G facility located in the Kakinada Special Economic Zone (SEZ). This facility is instrumental in reducing India's reliance on imported raw materials for essential antibiotics, Lokesh stated in a social media post.
Addressing Prime Minister Narendra Modi on X, Lokesh expressed his pride in Kakinada being at the heart of India's return to penicillin manufacturing. Modi echoed similar sentiments, tweeting, "Penicillin-G is being made in India, Again! India is strengthening its domestic pharmaceutical industry and reducing dependence on imported raw materials for medicines."
Under the Production Linked Incentive (PLI) scheme, India has invested over ₹5,000 crore and initiated around 40 projects to bolster pharmaceutical manufacturing, known as 'Aatmanirbharta.' The Union government quoted Modi as affirming these efforts.
Lyfius Pharma Private Limited inaugurated its Penicillin-G facility in Thodangi Mandal on October 29, 2024, with a ₹2,500 crore investment under the PLI scheme. This facility boasts an annual production capacity of 1,500 tonnes.
Written by urgent.news from The Hindu's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
